Fig. 2. ( A ) Effects of arginine-vasopressin (AVP, 1,000 pm) and terlipressin (100 nm) on coronary blood flow (CBF) and ( B ) maximal positive intraventricular pressure derivative (dP/dtmax) in control groups (n = 10) and after a pretreatment with the V1a-antagonist d(CH2)5Tyr(Me)AVP 0.1 μm (n = 6). P value refers to between-groups comparison. * P < 0.05 versus baseline value.